Telix Pharmaceuticals | TLX - Operating Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Telix Pharmaceuticals

Telix Pharmaceuticals Ltd reported AUD-24543000 in Operating Profit for its fiscal semester ending in December of 2022.


Operating Profit Change
Cochlear COH:AU AUD 185.7M 20.1M
CSL CSL:AU USD 2.13B 1.42B
Integral Diagnostics Ltd IDX:AU AUD 27.01M 14.07M
Mayne Pharma MYX:AU AUD -166537000 12.42M
Pacific Edge PEB:NZ NZD -17360000 2.66M
Paradigm Biopharmaceuticals Ltd PAR:AU AUD -31858670 19.38M
Polynovo Ltd PNV:AU AUD -3508410 837K
PYC Therapeutics Ltd PYC:AU AUD -16928800 9.16M
Ramsay Health Care RHC:AU AUD 511M 95M
ResMed RMD:AU USD 280.19M 4.46M
Sonic Healthcare SHL:AU AUD 578.99M 369.26M